glp-1 signaling pathway Unlocking the multifaceted roles of GLP-1: Physiological functions and therapeutic potential GLP-1-based therapies for type 2

they may be quietly reshaping the timing of reward

Lancet Gastroenterol Hepatol

Heres what stands out 1 Two Phase 2 wins, two different proof points Elecoglipron was evaluated in: #VISTA (Phase 2) 36-week weight-loss study vs placebo in 310 patients with obesity or overweight #SOLSTICE (Phase 2) glycemic control study vs placebo or semaglutide (active ingredient in Novo Nordisks #Wegovy) in 406 Type 2 diabetes patients Both studies hit their primary endpoints, clearing the bar for Phase 3

If you're considering tirzepatide for weight management, Zepbound is the FDA-approved injectable option available today.

Learn what food noise is, why it happens, and when its normal vs

Please be kind in the comments, Im just a girl If you are interested in signing up with Freya Meds I have it d in my bio #freya #freyameds #glp1 #glp1journey #weightloss @freyameds